C34H39N3O8 Cytidine, 5′-O-[bis(4-methocsaiphenyl)phenylmethyl]-2′-O-(2-methocsaiethyl)-5-methyl- (9CI, ACI)

Gàire Canònach O=C1N=C(N)C(=CN1C2OC(COC(C=3C=CC=CC3)(C4=CC=C(OC)C=C4)C5=CC=C(OC)C=C5)C(O)C2OCCOC)C
Isomeric SMILES C(OC[C@H]1O[C@H]([C@H](OCCOC)[C@@H]1O)N2C(=O)N=C(N)C(C)=C2)(C3=CC=C(OC)C=C3)(C4=CC=C(OC)C=C4)C5=CC=CC=C5
InChI
InChI=1S/C34H39N3O8/c1-22-20-37(33(39)36-31(22)35)32-30(43-19) -18-40-2)29(38)28(45-32)21-44-34(23-8-6-5-7-9-23,24-10-14-26(4) 1-3) 15-11-24) 25-12-16-27 (42-4) 17-13-25 / h5-17,20,28-30,32,38H,18-19,21H2,1-4H3,(H2,35,36,39)/t23-,
Iuchair InChI
LYKTVJJXZQTNPK-PBAMLIMUSA-N
24 Ainmean Eile airson an Stuff seo
5′-O-[Bis(4-methocsaiphenyl)phenylmethyl]-2′-O-(2-methocsaiethyl)-5-methylcytidine (ACI); 11: PN: US20030170636 DUILLEAG: 17 RNA tagraichte; 12: PN: US20030211606 DUILLEAG: 18 R NA tagraichte; 12: PN: US20030212017 DUILLEAG: 19 R NA tagraichte; 14: PN: US20040005569 DUILLEAG E: 21 R NA tagraichte; 15: PN: US20040005565 DUILLEAG: 17- 22 RNA tagraichte; 15: PN: US20040005570 DUILLEAG: 19 R NA tagraichte; 15: PN: U S20040006030 DUILLEAG: 22 air a thagradh R NA; 15: PN: US20040014048 DUILLEAG: 19 air a thagradh R NA; 16: PN: US20030171313 DUILLEAG: 9 air a thagradh RNA; 16: PN: US20030198965 DUILLEAG: 19 air a thagradh R NA; 16: PN: US20040014047 DUILLEAG: 19 air a thagradh R NA; 16: PN: US20040014049 DUILLEAG:

19 ag ràdh RNA; 17: PN: US20040014051 DUILLEAG: 21 ag ràdh R NA; 17: PN: US20040014699 DUILLEAG: 19 ag ràdh R NA; 17: PN: W
O03106645 DUILLEAG: 69 air a thagradh R NA; 18: PN: US20040006029 DUILLEAG: 22 air a thagradh R NA; 2′-O-Methoxyethyl-5′-O-dimethoxytrityl-5- methylcytidine; 58: PN: US20030166592 DUILLEAG: 15 air a thagradh R NA; 5: PN: WO2005006958 DUILLEAG: 61 air a thagradh R NA; 7: PN: WO20050 07825 DUILLEAG: 61 air a thagradh R NA; 82: PN: US20040171566 DUILLEAG: 18 air a thagradh R NA; 89: PN: US20040005707 DUILLEAG: 19 air a thagradh R NA; 9: PN: WO03084478 DUILLEAG: 56 air a thagradh R NA